Names, CVs (as available), locations and contact details of Investigators are available to Subscribers.
To subscribe, please contact Emma Taylor at emma@specialistinfo.com or 01423 727 724 for details on subscription costs. |
|
| Page No 1 2 3 4 5 6 7 8 9 10 11 |
| Phrase | Consultant | Town | Special Interests |
| head and neck surgical oncology | *Consultant(s)* | *Towns* | Oral and maxillofacial surgery, head and neck surgical oncology, management of craniofacial trauma and orbital injury, reconstructive surgery, microvascular surgical techniques for malignancy and acquired deformity, laser surgery |
| Head and neck surgical oncology and facial reconstruction | *Consultant(s)* | *Towns* | Head and neck surgical oncology and facial reconstruction, thyroid and parathyroid surgery, dental implants |
| hepatobiliary oncology | *Consultant(s)* | *Towns* | Medical oncology, colorectal cancer, oesophagogastric cancer, hepatobiliary oncology, neuroendocrine tumours, pancreatic cancer |
| interventional oncology | *Consultant(s)* | *Towns* | Interventional radiology, tumour ablation, interventional oncology |
| interventional oncology | *Consultant(s)* | *Towns* | Interventional radiology, vascular imaging, body imaging, interventional oncology |
| Laparoscopic urological oncology | *Consultant(s)* | *Towns* | Laparoscopic urological oncology, laparoscopic radical prostatectomy and nephrectomy, green light laser surgery to prostate, laser surgery for stone disease, robotic prostatectomy |
| lead oncology | *Consultant(s)* | *Towns* | Obstetrics, gynaecology, minimal access surgery, lead oncology, lead endometriosis |
| liaison psychiatry especially oncology | *Consultant(s)* | *Towns* | Substance abuse, perinatal psychiatry, liaison psychiatry especially oncology |
| Lymphoma/haematological oncology | *Consultant(s)* | *Towns* | Lymphoma/haematological oncology, stem cell transplantation |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, upper gastrointestinal cancer, hepatopancreatobiliary cancer, lung cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, bowel cancer, gynaecological oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer, cancer drug development, phase 1 - 2 trials |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, urological oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, renal cell carcinoma, thoracic malignancies |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer, lung cancer, testicular cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, non-small cell lung cancer, mesothelioma, small cell lung cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, acute oncology, kidney cancer, prostate cancer, bladder, cancer of unknown primary |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, hepatobiliary cancer, pancreatic cancer, melanoma, clinical trials |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, gynaecological malignancies, lung cancer, mesothelioma |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, prostate cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer, lung cancer, colorectal cancer, pancreatic cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, oesophagogastric cancer, pancreatobiliary cancer, colorectal cancer, neuroendocrine tumours |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, gynaecological oncology, ovarian cancer, translational research |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, testicular cancer, melanoma, renal cell cancer, Training Programme Director |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer, hormone therapy |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, gynaecological cancer, colorectal cancer, carcinoma unknown primary, malignant bowel obstruction |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, sarcoma |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, thoracic oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, ovarian cancer, angiogenesis, drug development |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, immunotherapy, lymphoma |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, sarcoma, soft tissue sarcoma, bone sarcoma |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, drug development, ovarian cancer, endometrial cancer, cervical cancer, early phase clinical trials |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, early and advanced breast cancer, role of novel therapies for cancer, novel targets in familial breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, ovarian cancer, clinical trials, experimental therapies |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, neuroendocrine tumours, rare cancers, oesophagogastric cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, bladder cancer, germ cell cancers, prostate cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer, colorectal cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, urological oncology, ovarian cancer, chemotherapy, immunotherapy |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, melanoma, liver cancer, inoperable cancer, phase 1 trials, upper gastrointestinal cancers |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, colorectal cancer, gastrointestinal cancer, cancer from unknown primary, liver directed therapy including selective internal radiation therapy - SIRT, DEBIRI, stereotactic radiation |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, acute oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, head and neck cancer, early phase clinical trials, immunotherapy |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, mesothelioma |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer |
| Page No 1 2 3 4 5 6 7 8 9 10 11 |
|
|
|
Third Party Advertisement
Adverts by Google
Favourites List
Enter the description for this link and click ok or to close, click the close button or use the ESC key.
Current Favourites
|
